Freedom to Operate Publishes Open Letter to Compass Pathways Challenging Validity of Psilocybin Patent
The non-profit, Freedom to Operate (FTO), has just published an open letter to Compass Pathways’ CEO, George Goldsmith, regarding the invalidity of one of Compass’ U.S. patents on psilocybin. Letter Serves to Put Compass on Notice Regarding Invalidity of U.S. Patent No. 11,149,044 The letter, which marks the fifth occasion on which FTO has disputed the validity […]
Continue Reading